Document Detail


Induction of labor following intrauterine death with intra-amniotic hyperosmolar urea and prostaglandin F2alpha: evaluation of placental endocrine function and changes in coagulation parameters.
MedLine Citation:
PMID:  453286     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A practicable and reliable method for inducing labor in patients whose pregnancies are complicated by intrauterine death of the fetus is described. The method involves the intra-amniotic instillation of 30 mg of prostaglandin F2alpha with 60 gm of urea. Twenty patients had pregnancies ranging between 22 and 41 weeks and the estimated duration of fetal death ranged between two and eight weeks. Delivery was achieved within 24 hours in all cases. Side effects and complications were minimal. Plasma human placental lactogen (hPL) and progesterone concentrations, as well as several blood coagulation parameters (i.e., plasma fibrinogen, blood platelet count, and serum fibrin degradation products (FDP) concentrations), were measured immediately prior to induction of labor. The latter (i.e., coagulation factors) were repeated at parturition. The presence of residual viable placenta prior to induction did not influence the induction-delivery interval. No statistically significant alterations in blood coagulation parameters that could be attributed to the specific method of induction employed were noted.
A practicable and reliable method for inducing labor in patients whose pregnancies are complicated by intrauterine death of the fetus is described. The method involves the intraamniotic instillation of 30 mg of prostaglandin F2alpha with 60 gm of urea. 20 patients were investigated with pregnancies ranging between 22 and 41 weeks and with the estimated duration of fetal death ranging between 2 and 8 weeks. In all cases, delivery was achieved within 24 hours. Prior to the induction of labor, plasma human placental lactogen (hPL); progesterone concentrations; and numerous blood coagulation parameters i.e., plasma fibrinogen, blood platelet count, and serum fibrin degradation products [FDP] concentrations) were measured. No statistically or clinically significant alterations occurred in the first 2 measurements, and FDP concentrations increased during labor in most patients. Side effects and complications were minimal and the induction-delivery interval was not influenced by the presence of residual viable placenta prior to induction. Thus, this method which only requires a single intraamniotic instillation is highly recommended.
Authors:
G Sher
Related Documents :
7266946 - Comparison of serum unconjugated estriol and estetrol in normal and complicated pregnan...
6638096 - Origin of prostanoids in human amniotic fluid: the fetal kidney as a source of amniotic...
15321286 - Breath pentane concentrations during labor and the effect of epidural analgesia on the ...
3221296 - Interpretation of the fetal ecg during labor: the effect of uterine contractions.
19703326 - Body fat, insulin resistance, energy expenditure and serum concentrations of leptin, ad...
8371226 - Postpartum cerebral infarction associated with aspirin withdrawal in the antiphospholip...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  134     ISSN:  0002-9378     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  1979 Jul 
Date Detail:
Created Date:  1979-08-29     Completed Date:  1979-08-29     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  493-7     Citation Subset:  AIM; IM; J    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amniotic Fluid
Blood Coagulation Factors / analysis*
Female
Fetal Death
Fever / etiology
Humans
Labor, Induced*
Placenta / secretion*
Placenta Accreta / diagnosis
Placental Lactogen / secretion
Pregnancy
Progesterone / secretion
Prostaglandins F
Urea
Chemical
Reg. No./Substance:
0/Blood Coagulation Factors; 0/Prostaglandins F; 57-13-6/Urea; 57-83-0/Progesterone; 9035-54-5/Placental Lactogen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  One-way maternal transport: an evolving concept. Inpatient services.
Next Document:  The effect of chlorotrianisene as postpartum lactation suppression on blood coagulation factors.